Three different clients asked me about peptides in a single week last month. A 47-year-old finance executive wanted to know if “stacking peptides” would help him get lean before his daughter’s wedding. A 39-year-old mom of two had been to a wellness clinic that quoted her $1,200 a month for a peptide protocol “for energy and recovery.” A retired professional athlete in his early 50s had been told that peptides would “reverse his aging” by an Instagram coach.
None of them had been medically prescribed anything yet. All of them had been marketed to aggressively. And all of them wanted me, their trainer, to tell them whether the spend was worth it.
The peptide industry is exploding for two reasons. The first is legitimate. GLP-1 medications like Ozempic, Wegovy, and Mounjaro have produced real, FDA-approved weight loss outcomes that no previous weight management drug class has matched, and they’re driving genuine consumer interest in peptide therapy more broadly. The second reason is less legitimate. The wellness industry has noticed the GLP-1 wave and is selling a much wider range of peptides, often without rigorous medical oversight, often with claims that go well past the evidence, and often at prices that would make a cardiologist blush.
This article is the honest breakdown of what’s actually happening in peptide therapy right now, which trends have evidence behind them, which trends are hype, and how to evaluate any peptide therapy option without falling for marketing dressed up as medicine.
Considering peptide therapy and want to evaluate it honestly? Start with a free consultation.
Latest Peptide Therapy Trends for Fat Loss and Performance
The current peptide therapy landscape is dominated by GLP-1 receptor agonists, which have transformed weight management since semaglutide received FDA approval for chronic weight management in 2021 under the brand name Wegovy. The category has since expanded to include tirzepatide (sold as Zepbound for weight management and Mounjaro for diabetes), and the next generation of compounds like retatrutide is in late-stage trials.
Outside the GLP-1 category, recovery and repair peptides like BPC-157, TB-500, CJC-1295, and Ipamorelin have grown in popularity through online communities, athletic circles, and wellness clinics. These compounds occupy a different regulatory space than the GLP-1 medications, and the evidence behind them ranges from moderate to weak depending on the specific compound and the specific claim.
What’s Actually Driving the Growth
Three forces are driving the peptide therapy boom. The first is GLP-1 medications, which have produced real outcomes in real patients and validated the broader category of peptide therapy in public consciousness. The second is direct-to-consumer marketing through telehealth platforms, which has made prescription peptides accessible to populations that previously wouldn’t have considered them. The third is influencer culture, which has aggressively promoted recovery and “anti-aging” peptides to athletic and wellness audiences regardless of evidence quality.
The first force is medical and legitimate. The third force is mostly marketing. The second force sits somewhere in between, depending on the prescribing platform and the compound.
Traditional Fat Loss vs Modern Peptide-Assisted Fat Loss
| Variable | Traditional Dieting | GLP-1 Peptides Alone | Coaching Plus GLP-1 Peptides |
| Appetite control | Willpower-dependent | Strong pharmacological suppression | Strong suppression with strategic eating |
| Adherence rate | Often poor over 6+ months | Higher early, drops with side effects | Highest sustained adherence |
| Muscle retention | Variable | Often poor without training | Strong if training is structured |
| Long-term sustainability | Hard for most adults | Depends on lifestyle changes | Highest probability of holding results |
| Cost | Low (food and effort) | High monthly medication cost | High medication cost plus coaching |
Notice that the strongest column isn’t the medication-only column. It’s the combination of coaching, training, and medication. This pattern repeats across the peptide therapy literature: the drug is a tool, and the surrounding lifestyle factors determine the actual body composition outcome.
Get a personalized body composition strategy that integrates training, nutrition, and medical care.
Emerging Peptide Therapies for Muscle Growth and Recovery
Outside the GLP-1 space, the peptides drawing the most attention for muscle growth, recovery, and tissue repair fall into three rough categories: growth hormone secretagogues, repair peptides, and IGF-1 modulators. None of these are FDA-approved for muscle building in healthy adults. Most are prescribed off-label, sourced through compounding pharmacies, or obtained through unregulated channels with varying safety and quality.
The Categories Worth Understanding
Growth hormone releasing hormones and growth hormone releasing peptides. Compounds like CJC-1295 (a GHRH analog) and Ipamorelin (a GHRP) stimulate the pituitary to release more endogenous growth hormone. They don’t replace growth hormone directly; they signal the body to produce more of its own. The evidence base is moderate. Clinical use cases include adult growth hormone deficiency under physician supervision.
Repair peptides. BPC-157 and TB-500 are the most discussed compounds in this category. They’re studied primarily for connective tissue repair, gut health, and inflammation modulation. Most of the strong evidence comes from animal studies. Human clinical data is limited, and these compounds are not FDA-approved for any indication.
IGF-1 modulators. Insulin-like growth factor 1 analogs target the IGF-1 pathway directly. They’re tightly regulated, often classified as performance-enhancing substances by athletic governing bodies, and rarely prescribed outside of specific medical conditions.
Recovery Methods Compared
| Recovery Approach | Evidence Strength | Cost | Best Use Case |
| Sleep, nutrition, walking | Very strong | Free | Foundation for all populations |
| Physical therapy and mobility work | Strong | Moderate | Targeted injury or imbalance |
| Hormone replacement (clinically indicated) | Strong | High | Medically diagnosed deficiency |
| Repair peptide therapy (BPC-157, TB-500) | Emerging, limited human data | High | Recovery interventions under physician guidance |
| GH secretagogue peptides | Moderate evidence | High | Adult GH deficiency under medical care |
| Influencer-promoted “stacks” | Weak to none | Very high | Not recommended |
The top three rows of the table outperform the bottom three rows for most recovery contexts, and they’re substantially cheaper. The lower rows have legitimate use cases, but those use cases are narrower than the marketing suggests.
Work with coaches who understand evidence-based recovery and body composition strategies.
What Peptide Therapy Trends Are Most Promising for Longevity?
The most evidence-supported longevity trends in peptide therapy are the same interventions that work for weight management and metabolic health: GLP-1 receptor agonists. They reduce body weight, improve glycemic control, reduce visceral fat, and have demonstrated cardiovascular benefit in trials like SELECT. Whether they extend lifespan in healthy populations is still being studied, but their effect on metabolic markers that correlate with longevity is well established.
Beyond GLP-1 medications, most “longevity peptides” being marketed aggressively have weaker evidence than their marketing suggests. The longevity field is genuinely interesting and the science is moving fast, but most consumer-facing peptide products are running ahead of the data.
Longevity Strategies Ranked by Evidence
| Strategy | Scientific Support | Cost | Sustainability | Risk Profile |
| Quality sleep (7-9 hours) | Very strong | Free | High | Very low |
| Regular resistance training | Very strong | Low | High | Very low |
| Mediterranean-style nutrition | Strong | Moderate | High | Very low |
| Daily walking and movement | Very strong | Free | High | Very low |
| GLP-1 medications (for obesity) | Strong (FDA-approved indication) | High | Depends on continued use | Documented profile, manageable |
| Growth hormone secretagogues | Moderate (for clinical use) | High | Variable | Requires medical oversight |
| Regenerative peptides (BPC, TB-500) | Limited human data | High | Variable | Limited safety data at scale |
| “Anti-aging” peptide stacks | Weak to none | Very high | N/A | Often unregulated sources |
The top four rows produce more longevity benefit per dollar than the bottom four rows, by a wide margin. They’re also the rows that the wellness marketing world is least interested in selling, because they don’t generate recurring revenue.
The Marketing-Versus-Medicine Problem
The peptide industry has a marketing-versus-medicine problem. Compounds with limited human data are being sold as “anti-aging miracles” in wellness clinics, on Instagram, and through direct-to-consumer telehealth platforms. The marketing language gets ahead of the science, and the consumer ends up paying premium prices for compounds with weaker evidence than the lifestyle interventions that would deliver better outcomes for free.
The honest framing: peptides are not a substitute for the fundamentals. They are tools that may have specific use cases under medical supervision, and they are most useful when added to a foundation of training, nutrition, sleep, and stress management that’s already solid.
Peptides are tools, not substitutes for training and nutrition. Start with a proven foundation.
Popular Peptide Therapy Options for Weight Loss and Wellness
The peptide therapy options getting the most consumer attention right now fall into a few distinct categories, and the evidence quality varies dramatically across them.
FDA-approved weight management peptides. Semaglutide (Wegovy) and tirzepatide (Zepbound) are approved for chronic weight management in adults meeting specific BMI criteria. These are the gold standard category. They have rigorous clinical trial data, FDA oversight, and known side effect profiles. They’re prescribed through licensed physicians and dispensed through regulated pharmacies.
FDA-approved diabetes peptides used off-label. Semaglutide (Ozempic) and tirzepatide (Mounjaro) are approved for type 2 diabetes but commonly prescribed off-label for weight management. The active compound is identical to the weight-management versions, but the dose ranges differ.
Compounded versions of regulated peptides. Some pharmacies compound versions of semaglutide and tirzepatide. The legal status of these compounds is currently complicated and evolving. Quality and purity vary significantly between providers.
Off-label peptides through wellness clinics. Compounds like BPC-157, TB-500, CJC-1295, Ipamorelin, and others are sometimes prescribed through wellness clinics, anti-aging clinics, or telehealth platforms. These compounds are not FDA-approved for the indications they’re typically used for, and prescribing standards vary widely.
Research peptides sold online. A separate category of compounds is sold online as “research chemicals not for human use,” even when both the seller and buyer understand the products will be used personally. This is the highest-risk category. Quality, purity, and sterility are not regulated, and there is no medical oversight.
Where Most Consumer Interest Sits
Most consumer interest currently sits in the first three categories: FDA-approved compounds for weight management, FDA-approved diabetes compounds prescribed off-label, and compounded versions of the same compounds. These represent the most legitimate end of the market.
The fourth and fifth categories carry significantly higher risk profiles, and the marketing around them is often more aggressive than the evidence supports.
How Is Peptide Therapy Changing Body Recomposition Strategies?
Peptide therapy, specifically GLP-1 medications, has changed body recomposition strategies in two main ways. The first is that significant weight loss is now achievable for populations that struggled with traditional dieting approaches alone. The second, less discussed, is that the muscle preservation challenge during medication-assisted weight loss is genuinely harder than during traditional dieting, and it requires more deliberate training and nutrition to manage.
The Muscle Preservation Problem on GLP-1 Medications
GLP-1 medications suppress appetite. When appetite is suppressed, total food intake drops, and protein intake typically drops the most because protein-rich foods are often less appealing and take more effort to prepare than convenient carbohydrate-heavy options.
Lower protein intake during a caloric deficit accelerates muscle loss. Clinical data suggests that 25 to 40 percent of weight lost on GLP-1 medications without structured exercise comes from lean tissue. That’s a significant share of the total weight loss showing up as muscle rather than fat.
The body composition outcome at 12 months looks very different for a patient who lost 30 pounds on Wegovy without training compared to a patient who lost the same 30 pounds while resistance training three times per week and hitting protein targets daily. Same scale weight. Completely different body underneath.
Body Recomposition Approaches Compared
| Approach | Speed of Results | Muscle Retention | Sustainability | Complexity |
| Training only | Slow | Excellent | High | Moderate |
| Nutrition plus training | Moderate | Excellent | High | Moderate |
| GLP-1 medication alone | Fast | Poor | Moderate (requires continued use or lifestyle change) | Low |
| GLP-1 plus structured training and nutrition | Fast | Strong (with deliberate protein and lifting) | High | Moderate |
| Full clinical optimization (multiple interventions) | Fast | Variable | Variable | High |
The fourth row produces the best body composition outcome for patients on GLP-1 medications. The third row produces the fastest scale results but the worst underlying body composition.
The Coaching Integration Trend
A growing share of peptide therapy clinics now integrate coaching, training programming, and nutrition support alongside the medication prescription. This is the trend that actually produces results for patients. The medication handles appetite. The coaching handles the lifestyle execution that determines whether the weight loss is fat or muscle.
For patients considering GLP-1 medications, the highest-yield question to ask the prescribing clinic isn’t about dosing or escalation. It’s about how they support training, protein intake, and muscle preservation alongside the prescription.
High-Demand Peptide Therapies for Athletes and High Performers
High-performing professionals and athletes drive significant demand in the peptide therapy market, often through wellness clinics that market recovery, performance, and longevity benefits. The reality is more complicated than the marketing.
Performance Peptide Demand
The peptides most commonly requested in performance contexts include CJC-1295 and Ipamorelin (for growth hormone optimization), BPC-157 and TB-500 (for recovery and tissue repair), and various IGF-1 modulators. None of these are FDA-approved for performance enhancement. Most are prescribed off-label or sourced through compounding pharmacies.
Anti-Doping Considerations
For competitive athletes, peptide use creates significant doping risk. The World Anti-Doping Agency prohibits many of these compounds, and the testing protocols are sophisticated enough to detect them. Professional athletes who use peptide therapy outside of medically necessary contexts face career consequences if they’re caught.
For non-competitive recreational athletes, this risk doesn’t apply, but the medical considerations remain.
Executive Wellness Programs
Executive wellness programs have emerged as a major channel for peptide therapy, often bundled with hormone optimization, IV therapy, advanced bloodwork, and concierge medicine. These programs can deliver real value for the right patient under genuine medical supervision, but the price points are substantial and the evidence behind many of the protocols is thinner than the marketing suggests.
The honest framing for high-performing professionals considering executive wellness peptide programs: the foundational lifestyle interventions (sleep, training, nutrition, stress management) deliver more measurable benefit than most of the peptide additions, and they cost nothing.
Evidence-based coaching beats trend-chasing every time.
Which Peptide Therapy Trends Deliver Real, Measurable Outcomes?
The peptide therapy trends with the strongest evidence for measurable outcomes are concentrated in a relatively narrow band of compounds and applications. Most of the broader category, especially the wellness-clinic and direct-to-consumer end, has weaker evidence than the marketing suggests.
Strongest Evidence
GLP-1 receptor agonists for obesity management. Semaglutide and tirzepatide have rigorous trial data showing average weight loss of 14 to 22 percent of body weight over 68 to 72 weeks in adults with obesity. The cardiovascular benefit demonstrated in the SELECT trial for semaglutide adds another layer of clinical validation.
GLP-1 medications for type 2 diabetes. These compounds have decades of glycemic control data and represent the standard of care for many diabetic patients.
Moderate Evidence
Growth hormone secretagogues for clinically diagnosed adult growth hormone deficiency. CJC-1295, Ipamorelin, and Sermorelin have moderate evidence for their use in physician-supervised settings to support endogenous growth hormone production in patients with documented deficiency.
Specific recovery peptides for soft tissue injuries in some clinical contexts. BPC-157 has emerging human data, but most of the strong evidence still comes from animal studies. TB-500 has similar limitations.
Weak or Overhyped Claims
Claims that any peptide produces dramatic muscle growth in healthy lifters who aren’t deficient. The growth signal from training and nutrition is much stronger than the supplemental signal from secretagogues in young, healthy lifters with normal hormone levels.
Claims of dramatic anti-aging reversal. Peptides may support specific aspects of metabolic health, recovery, or hormone optimization, but they don’t reverse aging in any clinically meaningful sense. The marketing language often outruns the science by a wide margin.
Claims of “biohacking miracles” or guaranteed transformation. The compounds that genuinely work, like GLP-1 medications, work for specific FDA-approved indications under medical supervision. They are not miracles. They are tools with specific use cases, side effects, and limitations.
Key Takeaway: The peptide therapy trends with the strongest evidence are GLP-1 medications for obesity and diabetes management. Most other peptide applications have weaker evidence than their marketing suggests, and the strongest predictors of body composition outcomes remain training, nutrition, sleep, and consistency.
New Peptide Therapy Applications in Metabolic Health and Energy
Metabolic health is one area where peptide therapy is producing genuine clinical advances. GLP-1 receptor agonists improve insulin sensitivity, reduce fasting glucose, lower HbA1c, reduce visceral fat, and improve cardiovascular risk markers. These are real, measurable, FDA-recognized benefits with strong trial data.
Beyond Glycemic Control
The metabolic effects of GLP-1 medications extend past blood sugar regulation. Patients on these compounds often see improvements in liver enzymes, blood pressure, sleep apnea symptoms, joint pain, and overall energy. Some of these effects are direct pharmacological actions. Others are downstream consequences of significant weight loss in patients who were carrying metabolic disease related to excess body fat.
For patients with metabolic syndrome, prediabetes, or type 2 diabetes, GLP-1 therapy can be transformative when prescribed appropriately. The challenge is that the medication doesn’t fix the underlying lifestyle patterns that contributed to the metabolic problem, so without parallel lifestyle change, the benefits don’t persist after the medication is discontinued.
The Lifestyle Integration Imperative
Peptide therapy for metabolic health works best when integrated with structured exercise, protein-priority nutrition, sleep optimization, and stress management. The medication creates a window of better appetite control and improved metabolic markers. The lifestyle interventions during that window determine whether the patient stays healthy after the medication ends.
This is the central thesis of evidence-based peptide therapy. The drug opens a door. The patient and the coaching system have to walk through it.
Current Peptide Therapy Protocols Used in Aesthetic Clinics
Aesthetic clinics, anti-aging clinics, and wellness clinics use a range of peptide protocols that vary significantly in evidence quality. Some clinics operate with rigorous medical oversight, comprehensive bloodwork, and conservative prescribing. Others operate closer to the marketing end of the spectrum, prescribing compounds with limited evidence at significant prices to patients without comprehensive medical evaluation.
Common Aesthetic Clinic Peptide Categories
GLP-1 medications for weight management, increasingly common in aesthetic settings. Growth hormone secretagogues for “aesthetic optimization” and “body recomposition.” Repair peptides for joint and skin health claims. Compounded combinations marketed as “personalized stacks.”
Warning Signs of Poor-Quality Peptide Clinics
The peptide clinics with the highest risk profiles share recognizable warning signs:
- Aggressive sales tactics or “limited time” pricing
- No baseline bloodwork or medical evaluation before prescribing
- Unrealistic outcome guarantees
- Generic vials without clear pharmaceutical sourcing
- Influencer-first marketing rather than medical-first communication
- No follow-up labs or monitoring protocols
- Resistance to coordinating with primary care or other physicians
- Vague answers about compound sourcing or compounding pharmacy oversight
If a clinic shows several of these signs, the risk of poor-quality compounds, inappropriate prescribing, or unmonitored side effects is significantly elevated.
What Higher-Quality Clinics Look Like
The clinics worth working with share a different profile:
- Comprehensive baseline bloodwork before any prescription
- Clear discussion of evidence quality and limitations
- Realistic discussion of expected outcomes
- Coordination with primary care physicians
- Ongoing monitoring labs throughout treatment
- Conservative dosing and clear discontinuation protocols
- Pharmaceutical-grade compound sourcing with documentation
- Integration of lifestyle coaching alongside medication
How to Evaluate New Peptide Therapy Options for Results
The framework for evaluating any peptide therapy option starts with the evidence and ends with the integration into your existing health context. A high-quality evaluation answers several specific questions before any prescription is filled.
The Evaluation Framework
Is the compound FDA-approved for the indication being prescribed? If yes, the evidence quality is generally strong. If the prescription is off-label, the evidence quality varies widely depending on the specific use case.
Who is the prescribing physician, and what is their oversight? A physician with relevant specialty training, appropriate state licensing, and ongoing patient monitoring is fundamentally different from a telehealth platform that prescribes after a 10-minute video visit with no follow-up.
What does baseline bloodwork show? Without comprehensive baseline labs, the prescription is happening blindly. Quality programs require baseline metabolic panels, hormone panels relevant to the compound being prescribed, and any specific markers tied to the medication’s known effects.
What are the realistic expected outcomes, and over what timeline? If the answer is a dramatic transformation in weeks, the evaluation is incomplete. Real outcomes from real peptides happen over months, not days, and are typically modest in scale even when meaningful.
How does this integrate with training, nutrition, sleep, and lifestyle? Any peptide therapy that doesn’t include this conversation is missing the variable that determines whether the medication delivers actual body composition results or just temporary appearance changes.
What is the discontinuation protocol? Most patients eventually discontinue peptide therapy. What happens to the results, the body composition, and the metabolic markers when the medication stops? A quality provider has thought about this question. A marketing-driven provider hasn’t.
When Peptide Therapy Is Worth Considering
Peptide therapy is worth considering when the patient has an FDA-approved indication and has already optimized the fundamentals as much as possible. When training, nutrition, sleep, and stress management are dialed in, and a specific clinical situation (obesity, diabetes, documented hormone deficiency) creates a legitimate medical case for adding a pharmacological tool.
Peptide therapy is rarely the right answer for a patient who hasn’t first optimized the lifestyle foundation. The fundamentals deliver most of the available outcomes in most cases, and adding medication to broken fundamentals usually produces disappointing results.
Expert Viewpoint: The Future of Peptide Therapy Is Personalization, Not Hype
Fifteen years of working with clients in New York has shown me one thing clearly about peptide therapy. The compounds that genuinely work, when prescribed appropriately and integrated with training and nutrition, can produce real results. The compounds that don’t work, or that have weaker evidence than their marketing, take money from patients without delivering on the promises.
The peptide therapy industry is at an inflection point. GLP-1 medications have validated the broader category and produced real outcomes for real patients. That’s the legitimate side of the trend. At the same time, the wellness marketing ecosystem has aggressively expanded the category to include compounds and protocols with much thinner evidence, marketed to populations who often don’t need them.
For most clients I work with, the right question isn’t “which peptide should I take?” It’s “have I done the foundational work that determines 80 percent of the outcome?” Training three or four times per week with progressive overload. Protein at 0.8 to 1 gram per pound of body weight. Seven to nine hours of sleep. Daily walking. Moderate caloric balance. Stress management. These fundamentals deliver more measurable benefit than most peptide additions, and they cost nothing.
When the fundamentals are dialed in and a specific clinical situation justifies medical intervention, peptide therapy can be a powerful additional tool. When the fundamentals are broken, peptide therapy is an expensive distraction from the work that actually drives results.
If you’re considering peptide therapy, the best move is bloodwork with a physician you trust, an honest conversation about your goals and your current lifestyle execution, and a realistic discussion of whether medication is the right next step or whether the foundational work needs to come first.
The future of peptide therapy is personalized, physician-supervised, and integrated with lifestyle coaching. The future is not Instagram-marketed peptide stacks sold through unregulated channels. Pick your providers accordingly.
Simple. Not easy. Absolutely achievable.
Build your strategy around evidence, not hype. Reach out for a consultation.
Frequently Asked Questions
What are the latest trends in peptide therapy?
The strongest current trends are GLP-1 receptor agonists like semaglutide and tirzepatide for weight management, alongside growing interest in growth hormone secretagogues and recovery peptides through wellness clinics, with evidence quality varying significantly across compounds.
Why is peptide therapy becoming so popular?
GLP-1 medications have produced real, FDA-approved weight management outcomes, which has driven legitimate medical interest and aggressive consumer marketing across the broader peptide category.
What peptides are trending for anti-aging and wellness?
Compounds like CJC-1295, Ipamorelin, BPC-157, and TB-500 are commonly marketed for anti-aging and wellness, though most have weaker evidence than the marketing suggests, with stronger evidence concentrated in specific clinical indications.
How is peptide therapy used in regenerative medicine?
Peptide therapy in regenerative medicine focuses on tissue repair, inflammation modulation, and growth hormone optimization, primarily through compounds like BPC-157, TB-500, and growth hormone secretagogues, often used under physician supervision for specific clinical contexts.
Are GLP-1 peptides part of modern peptide therapy trends?
Yes, GLP-1 medications like Ozempic, Wegovy, and Mounjaro are the dominant force in current peptide therapy trends, driving the broader category’s growth and legitimacy.
What are the benefits of peptide therapy in 2026?
Documented benefits include weight management and glycemic control through GLP-1 medications, with additional applications in specific clinical contexts under physician supervision, though many marketed benefits exceed current evidence.
Is peptide therapy safe for long-term use?
Long-term safety varies significantly by compound. FDA-approved peptides like semaglutide have multi-year safety data, while many other peptides have limited long-term data and should only be used under careful medical supervision.
How much does peptide therapy typically cost?
GLP-1 medications without insurance typically cost $900 to $1,500 per month, while other peptide protocols through wellness clinics range from $300 to over $2,000 monthly depending on the compound and provider.
What industries are driving peptide therapy market growth?
Pharmaceutical companies developing GLP-1 medications, telehealth platforms expanding access, wellness and aesthetic clinics, executive health programs, and direct-to-consumer compounding pharmacies are the primary drivers of peptide therapy market growth.
Where can you find reputable peptide therapy clinics?
Reputable clinics use comprehensive baseline bloodwork, coordinate with primary care, prescribe FDA-approved compounds for appropriate indications, monitor patients regularly, and integrate lifestyle coaching, while avoiding aggressive marketing or unrealistic guarantees.
Maik Wiedenbach is a New York City-based personal trainer, fitness author, and founder of Maik Wiedenbach Fitness. He has spent over 15 years helping clients evaluate fitness and wellness trends critically and build evidence-based body composition strategies that produce real results.
“`html
“`
Maik Wiedenbach is a Hall of Fame swimmer turned bodybuilding champion and fitness model featured in Muscle & Fitness and Men’s Journal. An NYU adjunct professor and award-winning coach, he founded New York’s most sought-after personal training gym.